Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers

Broadly neutralizing antibodies (bnAbs) against HIV-1 protect from infection and reduce viral load upon therapeutic applications. However no vaccine was able so far to induce bnAbs demanding their expensive biotechnological production. For clinical applications, nanobodies (VHH) derived from heavy c...

Descripción completa

Detalles Bibliográficos
Autores principales: Koch, Kathrin, Kalusche, Sarah, Torres, Jonathan L., Stanfield, Robyn L., Danquah, Welbeck, Khazanehdari, Kamal, von Briesen, Hagen, Geertsma, Eric R., Wilson, Ian A., Wernery, Ulrich, Koch-Nolte, Friedrich, Ward, Andrew B., Dietrich, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566552/
https://www.ncbi.nlm.nih.gov/pubmed/28827559
http://dx.doi.org/10.1038/s41598-017-08273-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566552/
https://www.ncbi.nlm.nih.gov/pubmed/28827559
http://dx.doi.org/10.1038/s41598-017-08273-7

Ejemplares similares